Fig. 2From: Model-based assessment of the safety of community interventions with primaquine in sub-Saharan AfricaPredicted reduction in hemoglobin levels after a single dose of 0.25Â mg/kg primaquine for a typical G6PD-normal and -deficient individual. A typical individual was assumed to have a weight of 70Â kg, length of 170Â cm, CYP2D6 activity score of 1.5 and pre-treatment hemoglobin of 13Â g/dlBack to article page